Quansanqi (derived from Panax notoginseng (Burk.) F. H. Chen) tablets extend the lifespan and ameliorate cellular inflammaging via regulating CD38 and senescence-associated secretory phenotype
Journal of Ethnopharmacology · 2026
DOI: 10.1016/j.jep.2025.120959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026. Verfasst von Yan Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Peking University-Yunnan Baiyao International Medical Research Center, Peking University Health Science Center, Beijing, 100191, China; Yunnan Instit…. Hauptthemen laut MEDLINE: Panax notoginseng, ADP-ribosyl Cyclase 1, Cellular Senescence, Longevity. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Quansanqi (PSQ) is derived from the whole plant of Panax notoginseng, including the flowers, stems, leaves, and roots. Its principal active ingredients include saponins, flavonoids, and polysaccharides. Unlike traditional P. notoginseng preparations, PSQ features a more diverse chemical composition. Aging is marked by systemic chronic inflammation, termed "inflamm-aging". Notably, PSQ exhibits significant anti-inflammatory properties. However, its anti-aging mechanism is unelucidated. AIM OF THE STUDY: This study aimed to determine the active ingredients of PSQ and the potential targets and mechanisms of PSQ against aging. MATERIALS AND METHODS: Anti-aging activity of PSQ was evaluated using yeast, Caenorhabditis elegans, zebrafish, and mice models. LPS-induced BMDMs were used to examine the anti-inflamm-aging mechanism of PSQ through molecular docking, molecular dynamics simulation, network pharmacology and experimental validation. RESULTS: PSQ increased yeast survival rates and average lifespan of C. elegans under natural conditions and exposure to H2O2. PSQ also extended the median and maximum lifespans of mice upon doxorubicin-induced aging. Furthermore, PSQ reduced the expression levels of p16, p21, and p53 mRNAs and β-gal contents in zebrafish with H2O2-induced aging. PSQ improved the survival rates of LPS-induced BMDMs and reduced the positive staining rates of β-gal and p53 protein expression. PSQ inhibited CD38 protein and mRNA expression while increasing intracellular NAD+ levels, and reduced the expression of several intracellular SASP molecules, including IL-1β, IL-6, TNF-α, and NO. Akt/MAPK/NF-κB were indicated to be key signaling pathways for inflamm-aging action of PSQ, and it inhibited CD38 and SASP expression. The main chemical components of PSQ exhibited good binding energy with the CD38 protein, and three of them were suggested to be specific to the flowers, stems, and leaves of P. notoginseng. CONCLUSION: PSQ exhibits significant anti-aging effects, extending lifespan in various aging models. CD38 and SASP may be the key targets of PSQ, with its regulatory effects mediated by Akt/MAPK/NF-κB pathway suppression. Flavonoids and saponins are the active anti-aging components of PSQ. Furthermore, the holistic utilization of the entire P. notoginseng plant aims to minimize resource wastage while enhancing its clinical value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peking University-Yunnan Baiyao International Medical Research Center, Peking University Health Science Center, Beijing, 100191, China; Yunnan Institute of Materia Medica, Kunming, 650111, China; Yunnan Province Company…
- Yunnan Institute of Materia Medica, Kunming, 650111, China; Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, 650111, China.
- Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
- Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Kunming, 650111, China.
- Peking University-Yunnan Baiyao International Medical Research Center, Peking University Health Science Center, Beijing, 100191, China. Electronic address: xiezhengwei@hsc.pku.edu.cn.
- Yunnan Institute of Materia Medica, Kunming, 650111, China; Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, 650111, China. Electronic address: zzy1370@163.com.
Zitieren
APA
Guo, Y., Yan, H., Zhong, C., Gong, L., Yang, W., Zi, Z., Li, T., Xu, Y., Wu, D., Wei, S., Cui, T., Xie, Z., & Zhu, Z. (2026). Quansanqi (derived from Panax notoginseng (Burk.) F. H. Chen) tablets extend the lifespan and ameliorate cellular inflammaging via regulating CD38 and senescence-associated secretory phenotype. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.120959
Vancouver
Guo Y, Yan H, Zhong C, Gong L, Yang W, Zi Z, et al. Quansanqi (derived from Panax notoginseng (Burk.) F. H. Chen) tablets extend the lifespan and ameliorate cellular inflammaging via regulating CD38 and senescence-associated secretory phenotype. Journal of Ethnopharmacology. 2026. doi:10.1016/j.jep.2025.120959
BibTeX
@article{Guo2026,
author = {Guo, Yan and Yan, Hong and Zhong, Chengzhi and Gong, Lvdong and Yang, Weifeng and Zi, Zhida and Li, Ting and Xu, Yi and Wu, Desong and Wei, Shanshan and Cui, Tao and Xie, Zhengwei and Zhu, Zhaoyun},
title = {Quansanqi (derived from Panax notoginseng (Burk.) F. H. Chen) tablets extend the lifespan and ameliorate cellular inflammaging via regulating CD38 and senescence-associated secretory phenotype},
journal = {Journal of Ethnopharmacology},
year = {2026},
doi = {10.1016/j.jep.2025.120959}
}
EUVIMED